低温预处理过程中大麦花药内源激素的变化

很多文章曾报道低温预处理可以明显提高大麦花药反应频率。但对于低温预处理的机理,至今研究报道甚少。我们应用ＥＬＩＳＡ方法测定了大麦花药低温预处理过程中内源激素ＩＡＡ、ｉＰＡ和ＡＢＡ含量。根据实验结果,推测低温预处理改变了花药内源ＩＡＡ和ｉＰＡ含量,阻断了花粉原来的发育方向,使其由配子体的发育途径转向孢子体的发育途径。     

草鱼垂体生长激素分离纯化及其抗体制备的研究

应用碱性抽提,亲和层析,凝胶过滤和离子交换层析等技术从草鱼垂体中分离提纯出纯度高的草鱼生长激素（ｇｃＧＨ）用酶联免疫吸附测定法（ＥＬＩＳＡ）检测表明草鱼ＧＨ与大马哈鱼ＧＨ抗血清具有明显的免疫交叉反应,而与大马哈鱼催乳素（ＰＲＬ）抗血清没有交叉反应,聚丙烯酰胺凝胶电泳表明草鱼ＧＨ为单一蛋白带,其分子量约为２２５００道尔顿,等电聚焦揭示出草鱼ＧＨ主要由等电点为４．７和５．０的两条蛋白带组成,用纯化的草     

中枢ACTH受体研究进展

除垂体以外,中枢神经系统也含有促肾上腺皮质激素（ＡＣＴＨ）能神经元,其神经纤维在中枢具有较广泛的投射。ＡＣＴＨ相关肽类在中枢发挥着多种生理功能。近年来对于中枢ＡＣＴＨ受体的研究取得很大的进展,现已确认ＡＣＴＨ结合位点在中枢具有广泛的分布。新近克隆出的四种ＡＣＴＨ受体中,有两种是中枢神经系统占优势的受体亚型。     

不同预处理对大麦花药3种内源激素含量和过氧化物酶活性的影响

研究了大麦（Ｈｏｒｄｅｕｍ ｖｕｌｇａｒｅ Ｌ．）花药－花粉培养中不同预处理对花药内源激素（ＡＢＡ,ＩＡＡ,ＩＰＡ）含量和过氧化物酶活性的影响。结果表明：１． 经甘露醇预处理不同天数,同一种基因型的３种内源激素的变化和不同基因型的同一种内源激素的变化规律十分相似,均是在预处理初期含量急剧增加,最高值在０．５或１ ｄ 处。以后开始逐渐下降;最后,保持在一定的水平上。２． 在甘露醇预处理过程中,两种基因型花药过氧化物酶活性的变化规律也十分相似。在预处理前期（从开始到第３天）活性呈直线上升,第３天达到最大值。从第３天到第５天活性减弱。最后,活性又开始增强。３． 在低温预处理过程的初期（２～５ ｄ） 两种基因型花药过氧化物酶活性都出现第一个小峰。在第１４天（“Ｈａｒｒｉｎｇｔｏｎ”）或第２１天（“Ｉｇｒｉ”）又出现第二个峰值,但后者较高。在预处理的后期（从第２８天到第３５天）两种基因型花药过氧化物酶的活性又呈现上升的趋势。同甘露醇预处理后期变化一致     

牛生长激素基因在马铃薯中的表达

将牛生长激素基因ｃＤＮＡ 与Ｐａｔａｔｉｎ ＣｌａｓｓＩ启动子及ＮＯＳ３终止子连接,构建了表达载体ｐＰＢＧＴ． 用直接法将表达载体转入农杆菌（Ａｇｒｏｂａｃｔｅｒｉｕｍ ｔｕｍ ｅｆａｃｉｅｎｓ） ＬＢＡ４４０４（ｐＲＡＬ４４０４）菌株, 用此菌株转化马铃薯（Ｓｏｌａｎｕｍ ｔｕｂｅｒｏｓｕｍ ）得到再生植株． 经ＮＰＴⅡ活性检测,总ＤＮＡ ＰＣＲ和Ｓｏｕｔｈｅｒｎ ｂｌｏｔ证明目的基因已整合到马铃薯基因组中．ＲＮＡ 点杂交和Ｗｅｓｔｅｒｎ ｂｌｏｔ表明牛生长激素基因已在转基因马铃薯块茎中转录和表达     

Identification,characterization, and developmental profile of a high molecular weight,juvenile hormone-binding protein in the hemolymph of the migratory grasshopper,Melanoplus sanguinipes

In the hemolymph of Melanoplus sanguinipes, a high molecular weight juvenile hormone binding protein (JHBP) was identified by photoaffinity labelling and found to have a M_r of 480,000. The JHBP, purified using native gel electrophoresis followed by electroelution, has an equilibrium dissociation constant for JH III of 2.1 nM and preferentially binds JH III over JH I. Antibody raised against JHBP recognized only the 480,000 band. Under denaturing conditions the native JHBP gave a single band with a M_r 78,000. The antibody against native JHBP recognized only the 78,000 protein in SDS-treated hemolymph samples, indicating that JHBP is a hexamer in this species. The concentration of JHBP fluctuates in both the sexes during nymphal and adult development in parallel with total protein content of hemolymph. © 1995 Wiley-Liss, Inc.     

Immunolocalization of a gonadotropin-releasing hormone receptor site in murine endometrium that mediates apoptosis

Circumstantial evidence from a previous study indicated that antibodies generated against a synthetic N-terminal extracellular domain mouse pituitary gonadotropin-releasing hormone (GnRH) receptor peptide acted directly on the murine uterus affecting endometrial regression. Affinity-purified polyclonal sheep antibodies were used to assess tissue-specificity of antibody reactions in diestrous mice. Antibody binding was localized by immunofluorescence staining to anterior pituitary gland and endometrium. Ovary, brain, liver, kidneys, heart, lungs, spleen, gastrointestinal tract, adrenal glands, thymus, thyroid gland, muscle, and adipose were unreactive. Fragmented deoxyribonucleic acid, a marker of programmed cell death/apoptosis, was detected by digoxigenin labeling-immunoperoxidase in endometrial (but not pituitary) glands of animals injected with antipeptide antibodies or native ligand. It appears that luteal phase endometrium of mice expresses a GnRH receptor moiety that is coupled to a cell death (endonuclease) transduction pathway.     

甾体激素受体超家族的基因调控机制

甾体激素受体超家族是一类基因反式作用因子,对RNA聚合酶Ⅱ转录的某些蛋白质基因和RNA聚合酶Ⅰ转录的核糖体RNA基因均有正或负的转录调节作用.超家族对RNA polⅡ转录的基因调控的机理包括受体激活,相关蛋白解离,磷酸化,同源/异源二聚化,核转位,与正/负激素应答元件及相应转录蛋白作用,最终激活或抑制特异靶基因的转录.甾体激素对RNA polⅠ转录的基因的调节作用以及超家族中的经典受体和孤儿受体非配合的激活机制是目前研究的热点.     

Effects of luteinizing hormone releasing hormone on gonadotrophins in the hamster

The changes in serum gonadotrophins in male hamsters following one injection of 15 μg luteinizing hormone releasing hormone (LHRH) (Group A) were compared with those following the last injection of LHRH in animals receiving an injection approximately every 12 hr for 4 days (Group B) or 12 days (Group C). Peak follicle stimulating hormone (FSH) levels (ng/ml) were 1776±218 (Group A), 2904±346 (Group B), and 4336±449 (Group C). Peak luteinizing hormone (LH) values (ng/ml) were 1352±80 (Group A), 410±12 (Group B), and 498±53 (Group C). Serum FSH:LH ratios, calculated from the concentrations measured 16 hr after the last LHRH injections, were higher in Groups B and C than in Group A. Similar injections of LHRH (100 ng or 15 μg/injection) for 6 days elevated the serum FSH:LH ratio in intact males. Five such LHRH injections (100 ng/injection) blunted the rise in serum LH in orchidectomized hamsters. Direct effects of LHRH on gonadotrophin secretory dynamics or altered brain-pituitary-testicular interactions may alter the ratio of FSH to LH in the hamster.     

Immunocytochemical localization of growth hormone releasing factor (GHRF)-containing structures in the rat brain using anti-rat GHRF serum

The distribution of growth hormone releasing factor (GHRF) immunoreactive structures in the rat hypothalmus was studied after colchicine treatment with PAP immunocytochemistry in vibratome sections using an antiserum directed to rat hypothalamic GHRF. The majority of the GHRF-immunoreactive cell bodies were found in the arcuate nucleus, the medial perifornical region, and the ventral premammillary nuclei of the hypothalamus. Scattered cells were seen in the lateral basal hypothalamus, the medial and lateral portions of the ventromedial nucleus, and the dorsomedial and paraventricular nuclei. Immunoreactive fibers were observed in all the regions mentioned above. GHRF terminals were located in the central region of the median eminence. In addition, GHRF-immunoreactive neuronal processes were seen in the ventral region of the dorsomedial nucleus, the medial preoptic and suprachiasmatic regions, dorsal portion of the suprachiasmatic nucleus, bed nucleus of the stria terminals and the hypothalamic portion of the stria terminals. The localization of GHRF-immunoreactive terminals in the median eminence reinforces the view that GHRF plays a physiological role in the regulation of pituitary function. In addition, the localization of GHRF-immunoreactive structures in areas not usually considered to project to the median eminence suggest that GHRF may act as a neuromodulator or neurotransmitter.